Current Opinion in Oncology

Papers
(The H4-Index of Current Opinion in Oncology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?59
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy41
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps38
Role of PSMA PET/CT in imaging and management of prostate cancer32
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis30
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation28
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review26
Treatments and challenges in advanced prostate cancer23
Harnessing dendritic cells for innovative therapeutic cancer vaccines23
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies21
Editorial introductions20
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies19
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes18
First and further-line multidisciplinary treatment of retroperitoneal sarcomas18
Psycho-oncology interventions focusing on fatigue and sleep disturbances17
Editorial introductions16
Importance of guidelines and networking for the management of rare gynecological cancers16
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies16
0.040616989135742